Magdalena Wysocka
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 8
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 14
- Microbiology top 10%
- Antimicrobial Peptides and Activities 5
-
- Biochemical and Structural Characterization 17
- Ubiquitin and proteasome pathways 6
- Chemical Synthesis and Analysis 6
- Insect Resistance and Genetics 5
-
- Peptidase Inhibition and Analysis 16
- Co-authors
- Adam LesnerKrzysztof RolkaAnna ŁęgowskaDawid DębowskiBrice KorkmazMarcin SieńczykKatarzyna GuzowAnna Jaśkiewicz
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
In The Last Decade
Magdalena Wysocka
58 papers receiving 829 citations
Peers
Comparison fields: 5 of 89
- Immunology and Allergy 81
- Cancer Research 175
- Microbiology 61
- Molecular Biology 490
- Oncology 189
Countries citing papers authored by Magdalena Wysocka
This map shows the geographic impact of Magdalena Wysocka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Wysocka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Wysocka more than expected).
Fields of papers citing papers by Magdalena Wysocka
This network shows the impact of papers produced by Magdalena Wysocka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Wysocka. The network helps show where Magdalena Wysocka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Magdalena Wysocka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 32 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 19 | |
| 9 | 2023 | 3 | |
| 10 | 2018 | 10 | |
| 11 | 2016 | 26 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 5 | |
| 14 | 2015 | 15 | |
| 15 | 2014 | 34 | |
| 16 | 2013 | 21 | |
| 17 | 2010 | 12 | |
| 18 | 2009 | 0 | |
| 19 | 2008 | 12 | |
| 20 | 2008 | 5 |
About Magdalena Wysocka
Magdalena Wysocka is a scholar working on Immunology and Allergy, Cancer Research and Microbiology, having authored 63 papers that have together received 836 indexed citations. Recurring topics across this work include Biochemical and Structural Characterization (17 papers), Peptidase Inhibition and Analysis (16 papers), Protease and Inhibitor Mechanisms (14 papers), Cell Adhesion Molecules Research (8 papers), Ubiquitin and proteasome pathways (6 papers), Chemical Synthesis and Analysis (6 papers), Insect Resistance and Genetics (5 papers) and Antimicrobial Peptides and Activities (5 papers). The work is most often cited by research in Immunology and Allergy (81 citations), Cancer Research (175 citations) and Microbiology (61 citations). Magdalena Wysocka has collaborated with scholars based in Poland, France and Germany. Frequent co-authors include Adam Lesner, Krzysztof Rolka, Anna Łęgowska, Dawid Dębowski, Brice Korkmaz, Marcin Sieńczyk, Katarzyna Guzow, Anna Jaśkiewicz, Wiesław Wiczk and André Freitas. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.